Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Lowers Stock Holdings in UnitedHealth Group Inc (NYSE:UNH)
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA decreased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,524 shares of the healthcare conglomerate’s stock after selling 236 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in UnitedHealth Group were worth $787,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Vanguard Group Inc. raised its position in UnitedHealth Group by 7.5% during the second quarter. Vanguard Group Inc. now owns 80,727,140 shares of the healthcare conglomerate’s stock valued at $23,810,470,000 after purchasing an additional 5,654,194 shares in the last quarter. Fisher Asset Management LLC raised its position in UnitedHealth Group by 41,127.3% during the second quarter. Fisher Asset Management LLC now owns 2,347,070 shares of the healthcare conglomerate’s stock valued at $692,268,000 after purchasing an additional 2,341,377 shares in the last quarter. Nordea Investment Management AB raised its position in UnitedHealth Group by 103.1% during the second quarter. Nordea Investment Management AB now owns 2,827,796 shares of the healthcare conglomerate’s stock valued at $817,176,000 after purchasing an additional 1,435,755 shares in the last quarter. GQG Partners LLC raised its position in UnitedHealth Group by 50.0% during the second quarter. GQG Partners LLC now owns 2,105,870 shares of the healthcare conglomerate’s stock valued at $621,353,000 after purchasing an additional 702,164 shares in the last quarter. Finally, Two Sigma Advisers LP increased its holdings in shares of UnitedHealth Group by 195.8% in the second quarter. Two Sigma Advisers LP now owns 760,600 shares of the healthcare conglomerate’s stock worth $224,339,000 after buying an additional 503,500 shares during the period. Institutional investors and hedge funds own 86.39% of the company’s stock.
Several research analysts have recently commented on UNH shares. Citigroup lifted their price objective on UnitedHealth Group from $339.00 to $357.00 and gave the stock a “buy” rating in a report on Thursday, July 16th. UBS Group lifted their price objective on UnitedHealth Group from $319.00 to $330.00 and gave the stock a “neutral” rating in a report on Friday. Piper Sandler lifted their price objective on UnitedHealth Group from $350.00 to $385.00 and gave the stock an “overweight” rating in a report on Thursday. Oppenheimer lifted their price objective on UnitedHealth Group from $353.00 to $375.00 and gave the stock an “outperform” rating in a report on Thursday. Finally, Bank of America lifted their price objective on UnitedHealth Group from $351.00 to $365.00 and gave the stock a “buy” rating in a report on Friday, August 28th. Four analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $346.68.
Shares of UNH opened at $329.90 on Friday. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.60. The business’s 50 day moving average price is $311.35 and its 200-day moving average price is $297.69. UnitedHealth Group Inc has a 52 week low of $187.72 and a 52 week high of $333.70. The stock has a market cap of $313.52 billion, a P/E ratio of 18.55, a P/E/G ratio of 1.44 and a beta of 0.68.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 EPS for the quarter, topping analysts’ consensus estimates of $2.98 by $0.53. UnitedHealth Group had a return on equity of 29.28% and a net margin of 6.90%. The firm had revenue of $65.12 billion for the quarter, compared to analysts’ expectations of $63.97 billion. During the same period in the previous year, the firm posted $3.88 EPS. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. On average, equities analysts anticipate that UnitedHealth Group Inc will post 16.58 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a $1.25 dividend. The ex-dividend date was Friday, September 11th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 33.09%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Support Level
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.